Ollie's (NASDAQ:OLLI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.4%

Ollie's Bargain Outlet (OLLI) reported Q2 CY2026 revenue of $741.3M, up 9.1% YoY but below estimates. Full-year guidance was slightly below analysts' expectations. Non-GAAP EPS of $1.42 beat estimates by 26.5%. The stock rose 5.4% post-earnings. The company cited strong deal flow and reinvestment in pricing.

Original reporting
Published Sep 2, 2026, 11:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ollie's (NASDAQ:OLLI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.4% — source image
Decision brief

The 30-second read

$OLLIBullishMed
01

Why it matters

Earnings beat on profit but miss on revenue; guidance below expectations may temper enthusiasm.

02

Market read

Earnings release provides fresh data for traders; stock already rallied, indicating immediate market impact.

03

What to watch

Store expansion pace and inventory management may drive future performance more than quarterly earnings.

Relevance 7/10Novelty 7/10Timing: post‑market reaction

Background

Ollie's Bargain Outlet is a discount retailer focused on close‑out merchandise, operating ~686 stores.

Company-level read

Ticker impact

$OLLIBullishMedium confidence
Context

Q2 CY2026 earnings miss revenue estimates, guidance below consensus, stock up 5.4% post‑release.

Expected impact

Potential further upside if guidance is revised upward; downside risk if same‑store sales decline continues.

Evidence & confidence

Revenue miss may pressure near‑term, but profit beat and 5% price jump suggest bullish sentiment.

Market effects

Discount retail sector may see increased scrutiny on same‑store sales trends.

U.S. consumer discretionary stocks could be modestly affected.

Limited to U.S. retail investors.

Counterpoint

Revenue miss and declining same‑store sales could signal longer‑term weakness despite short‑term rally.

Key entities

  • Ollie's Bargain Outlet

    Discount retailer reporting Q2 CY2026 results.

Related articles

$OLLIHighAI 8/10

Why is Ollie’s Bargain Outlet stock rallying today?

Ollie’s Bargain Outlet (OLLI) stock rose 2.3% after reporting Q2 fiscal 2026 results. Net sales increased 9.1% YoY, and adjusted EPS rose 43.4% to $1.42, beating estimates. Comparable store sales declined 1.8%, but the company raised gross margin and EPS guidance. The stock had fallen 32% YTD before the earnings report.

$OLLIHigh

Ollie's Bargain Outlet Holdings, Inc. (OLLI): Results of Operations and Financial Condition

Ollie's Bargain Outlet Holdings, Inc. (OLLI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ollie’s Bargain Outlet Holdings, Inc. Announces Second Quarter Fiscal 2026 Results Net Sales Increased 9.1% Opened 15 New Stores and Grew Ollie’s Army 12.7% Updating Outlook for Fiscal 2026 HARRISBURG, PA – September 2, 2026 – Ollie’s Bargain Outlet Holdings, Inc. (N

$STLAMed

Why Did STLA, OLLI, SMR Stocks Hit 52-Week Lows Today?

Stellantis (STLA), Ollie’s Bargain Outlet (OLLI) and NuScale Power (SMR) hit fresh 52-week lows amid worries about slower growth, higher costs and uncertain timelines. STLA fell to $5.33 after a JPMorgan downgrade to Neutral and a cut to a $6.85 target. OLLI slid to $61.61 after JPMorgan cut its target to $70. SMR touched $8.55 after a larger-than-expected Q1 loss and revenue decline.

$STLAMed

Stellantis (NYSE: STLA), Ollie’s Bargain Outlet (NASDAQ: OLLI), And NuScale Power (NYSE: SMR) Crash To 52-Week Lows On Growth And Cost Fears

Stellantis (STLA), Ollie’s Bargain Outlet (OLLI), and NuScale Power (SMR) hit fresh 52-week lows on growth and cost worries. Stellantis fell to $5.33 despite 6% YoY Q2 U.S. sales growth; JPMorgan cut its STLA target to $6.85. OLLI dropped to $61.61; JPMorgan cut its target to $70 and lowered Q2 EPS/sales. SMR fell to $8.55 after a larger-than-expected Q1 loss and 96% revenue decline.